All articles tagged with #licorice
Researchers used a lab-grown human intestinal model to screen about 3,500 compounds for treating inflammatory bowel disease (IBD). Glycyrrhizin, a compound from black licorice, emerged as a strong candidate, reducing intestinal cell death and inflammation in the model and showing similar protective effects in mice, indicating potential for clinical development pending further studies.
A study conducted in Hong Kong has found that isoliquiritigenin (ISL), a compound found in black licorice, could potentially suppress the growth of pancreatic cancer cells and enhance the effectiveness of chemotherapy. When injected into tumors, ISL reduced the survival rate of cancer cells and induced cell death. Additionally, ISL was found to inhibit the growth of pancreatic cancer cells when combined with chemotherapy drugs. While the research is still in its early stages, the findings offer a promising avenue for developing ISL as a novel treatment for pancreatic cancer. However, the public is advised against consuming large amounts of licorice as a preventive measure, and further evaluation of ISL's effectiveness and clinical application is needed.